AMN’s business model is fundamentally strong, with high recurring revenue, robust customer growth, and clear opportunities for TAM expansion via digital and tech-enabled services. Margins are normalizing and remain under pressure in tech/language segments, limiting margin durability. The company is…
AMN Healthcare (AMN) Q2 2026: Nurse and Allied Orders Up 40%, Signaling Sustained Demand Surge
AMN Healthcare delivered a notable beat in Q2 2026, driven by a broad-based acceleration in nurse and allied staffing demand and outperformance in core segments. The company’s momentum is underpinned by rising order volumes, robust fill rates, and targeted M&A, despite ongoing margin normalization and pricing pressure in technology solutions. With demand tailwinds and improved operational agility, AMN is positioning for continued share gains and industry consolidation.
Summary
- Order Momentum Accelerates: Nurse and allied staffing orders surged, with travel nurse orders up 40% year-over-year in early August.
- Margin Normalization Underway: Core margins remain stable, but mix shift and pricing pressure in technology solutions weigh on segment profitability.
- Strategic M&A and Platform Investments: Recent acquisitions and digital platform adoption enhance AMN’s competitive position for long-term growth.
Business Overview
AMN Healthcare is a leading provider of healthcare workforce solutions, specializing in contingent staffing, permanent placement, and technology-enabled services for hospitals and healthcare systems. The company operates three main segments: Nurse and Allied Solutions (temporary and international nurse staffing, allied health professionals), Physician and Leadership Solutions (locum tenens, executive and physician search, interim leadership), and Technology and Workforce Solutions (vendor management systems, language services, workforce analytics). Revenue is primarily generated through staffing placements and technology-driven workforce optimization contracts.
Performance Analysis
Q2 2026 results exceeded expectations, propelled by a sharp rebound in nurse and allied staffing demand and tactical execution on labor disruption events. Nurse and Allied Solutions, AMN’s largest segment, delivered 11% year-over-year revenue growth, outperforming consensus by 12%. Travel nurse and allied volumes each posted their highest growth rates in four years, with order acceleration continuing into Q3. Segment gross margin was 28.4%, supported by temporary billing accruals and reserve reversals that will not recur in Q3, but underlying margins remained solid.
Physician and Leadership Solutions revenue declined 6% year-over-year, but search activity surged, with new physician searches up 40% and executive search up 30%. Locum tenens and interim leadership remain pressured by competitive fill rates and slower client hiring. Technology and Workforce Solutions revenue fell 15% year-over-year, impacted by pricing compression in language services and the divestiture of SmartSquare. Gross margin in this segment, while still high at 48.6%, is under pressure from lower pricing and mix shift.
- Order Acceleration: Travel nurse orders turned positive in May and rose 40% YoY in early August, driving visibility into H2 demand.
- Technology Platform Scale: Passport app adoption surpassed 400,000 users, up 33% YoY, with monthly active users up 50%, expanding AMN’s clinician network.
- Acquisition-Driven Capability Expansion: Two small deals in language services and leadership assessment extend AMN’s reach into adjacent, tech-enabled solutions.
AMN’s strong cash position ($362 million) and low leverage (1.5x) provide ample flexibility for further investment and opportunistic M&A, supporting its ambition to be both an active participant and beneficiary of industry consolidation.
Executive Commentary
"Our second quarter results came in better than we forecasted, with five of our solutions growing revenue year over year. Travel Nurse volume showed 6% year-over-year growth and Allied volume grew 7%, both the highest growth rate these businesses have achieved in four years. As of early August, the improvement continued with orders up about 40% year-over-year and 20% higher than August 2024."
Kerry Grace, President and Chief Executive Officer
"Our consolidated results benefited from several items that are not expected to recur in the third quarter... Excluding these items, our Q2 revenue would still be almost 2% above the high end of our guidance range, and our EBITDA margin would be at the top end of our 6.7% to 7.2% guidance."
Brian Scott, Chief Financial and Operating Officer
Strategic Positioning
1. Nurse and Allied Demand Tailwind
AMN is capitalizing on a broad-based surge in nurse and allied staffing demand, with fill rates rising across managed service provider (MSP), vendor-neutral, and third-party channels. Improved process automation and AI-enabled recruiting are driving higher fulfillment and supporting double-digit volume growth guidance for Q3.
2. Technology-Enabled Differentiation
Digital adoption is scaling, with the Passport app’s clinician network surpassing 400,000 users and monthly active users up 50% year-over-year. Enhancements in workforce analytics and AI-enabled features are strengthening AMN’s value proposition in workforce optimization and engagement.
3. M&A and Platform Expansion
Two targeted acquisitions—Jade Health (AI-enabled language services) and Essential Brand Leadership Assessment— extend AMN’s capability set, positioning the company for deeper integration into client workflows and adjacent services. Management signaled increased appetite for active participation in industry consolidation as more assets come to market.
4. Margin Management and Cost Discipline
Margin normalization is underway, with Q2 benefiting from one-time items, but core margins remain stable. SG&A discipline and global workforce strategies in technology services are intended to stabilize and improve gross margin in 2027.
5. Competitive Share Capture
AMN is gaining share through superior fill rates and execution, especially in competitive third-party channels. Management attributes this to operational agility, digital process investments, and proactive client targeting amid competitor disruption.
Key Considerations
This quarter marks a pivotal inflection in AMN’s demand environment, with broad-based order growth, digital platform scale, and new solution adjacencies. The company is leveraging its balance sheet to position for long-term market leadership, but faces ongoing pricing and margin headwinds in technology and language services.
Key Considerations:
- Order Growth Visibility: Early Q3 order trends support continued volume momentum in nurse and allied, providing near-term revenue visibility.
- Margin Headwinds in Tech Solutions: Pricing compression and mix shift in language services are weighing on segment profitability, with normalization expected in 2027.
- International Nurse Growth Constraints: Embassy appointment backlogs are likely to moderate international nurse growth in 2027, despite strong underlying demand.
- Active Role in Consolidation: Management is prepared for opportunistic M&A, as industry consolidation accelerates and more assets come to market.
- Leadership Bench Strength: New Chief People Officer and Chief Commercial Officer hires reinforce AMN’s focus on talent strategy and integrated go-to-market execution.
Risks
AMN faces risk from pricing pressure and competitive intensity in technology and language services, as well as potential normalization of nurse and allied demand if hospital permanent hiring rebounds. Regulatory or immigration policy shifts could further impact international nurse supply. Major client contract renewals, such as the Kaiser RFP, introduce potential for margin compression or share loss if terms reset unfavorably. Management’s guidance embeds these uncertainties, but sustained order momentum is critical to maintaining growth trajectory.
Forward Outlook
For Q3 2026, AMN guided to:
- Consolidated revenue of $640 to $655 million
- Gross margin of 27% to 27.5%
- Adjusted EBITDA margin of 6.5% to 7%
For full-year 2026, management maintained a constructive outlook for core nurse and allied volume growth, but flagged:
- Technology and workforce solutions revenue expected down 11% to 13% YoY in Q3
- Physician and leadership solutions revenue projected down 5% to 7% YoY in Q3
Management cited continued acceleration in nurse and allied orders, margin normalization after one-time items, and active pipeline for tuck-in acquisitions as key drivers for the back half of 2026.
Takeaways
AMN Healthcare’s Q2 2026 results underscore a decisive shift in demand dynamics, with broad-based order growth and operational execution driving outperformance in core staffing segments.
- Volume-Led Outperformance: Travel nurse and allied orders are surging, supporting double-digit volume growth into Q3 and offsetting margin normalization elsewhere.
- Strategic Platform Expansion: Digital adoption and targeted M&A are enhancing AMN’s competitive moat, positioning the company for share gains and deeper client integration.
- Watch for Margin and Pricing Trends: Investors should monitor the sustainability of order momentum, the evolution of bill rates, and the pace of normalization in technology services margins as key signals for future quarters.
Conclusion
AMN Healthcare enters the second half of 2026 with substantial order momentum, digital scale, and strategic flexibility to capitalize on industry consolidation and evolving client needs. While margin headwinds and pricing pressure persist in select segments, the company’s operational agility and balance sheet strength provide a solid foundation for continued growth and market leadership.
Industry Read-Through
AMN’s results signal a broader recovery in healthcare staffing demand, with travel nurse and allied order acceleration likely to benefit other large staffing providers and digital platforms. The normalization of contingent labor premiums and the shift toward flexible, tech-enabled workforce solutions reflect secular trends across healthcare services. Competitive intensity in language services and workforce technology will continue to pressure margins industry-wide, favoring scale players with differentiated platforms. Ongoing industry consolidation is set to reshape the competitive landscape, with well-capitalized leaders best positioned to drive and benefit from M&A activity.